Peripheral Vascular Devices Market Analysis, Size, Trends - Europe - 2023-2029 - MedSuite - Includes: Peripheral Vascular Stent Market, Stent Graft Market,Transcatheter Embolization Market & 15 more
In 2022, the European market for peripheral vascular devices reached a valuation of approximately €1.5 billion. As we look ahead, it is expected to experience a steady growth rate with a projected CAGR of 3.1% during the forecast period, ultimately reaching around €1.9 billion.
Our extensive medical device market research encompassed an analysis of over 50 companies operating within the peripheral vascular device market across Europe. Through our comprehensive methodology, we delved into various aspects including market sizes, unit sales, company market shares, and average sales prices (ASPs) to provide accurate forecasts.
The full report suite on the European peripheral vascular (PV) devices market offers a comprehensive analysis of a wide range of devices including peripheral vascular stents, percutaneous transluminal angioplasty (PTA) balloon catheters, drug-coated balloons (DCBs), atherectomy devices, intravascular lithotripsy (IVL) systems, chronic total occlusion (CTO) devices, surgical grafts, stent grafts, embolic protection devices (EPDs), arteriovenous (AV) access thrombectomy devices, inferior vena cava filters, carotid shunts, diagnostic and interventional catheters, diagnostic and interventional guidewires, introducer sheaths, vascular closure devices (VCDs), transcatheter embolization devices, and peripheral intravascular ultrasound (IVUS) catheters. Our in-depth analysis provides valuable insights into this dynamic market.
DATA TYPES INCLUDEDUnit Sales, Average Selling Prices, Market Value & Growth Trends
Forecasts Until 2029, and Historical Data to 2019
Market Drivers & Limiters for Each Peripheral Vascular Device market
Competitive Analysis with Market Shares for Each Segment
Recent Mergers & Acquisitions
Disease Overviews and Demographic Information
Company Profiles, Product Portfolios and SWOT for Top Competitors
EUROPEAN PERIPHERAL VASCULAR DEVICES MARKET INSIGHTSThe COVID-19 pandemic had a significant impact on the European peripheral vascular (PV) market in 2020. Lockdown measures and procedure delays led to reduced demand and lower sales for PV device companies. However, as restrictions eased and procedures resumed, the PV market started to recover. In 2021 and 2022, there was a noticeable increase in demand for PV devices as postponed procedures were addressed. This recovery demonstrates the resilience of the PV market in Europe.
The IVL (Intravascular Lithotripsy) market in Europe has witnessed significant growth in recent years. This advanced technology employs sound waves to disrupt calcium deposits in arteries, offering a more effective and minimally invasive alternative to conventional treatments for peripheral arterial disease. The escalating prevalence of peripheral artery disease, coupled with the rising demand for less invasive treatment options, has fueled the increasing adoption of IVL in Europe.
EUROPEAN PERIPHERAL VASCULAR DEVICES MARKET SHARE INSIGHTSIn 2022, Medtronic emerged as the leading player in the European PV market, leveraging its strong presence in the stent graft segment and diverse product portfolio. The company's ability to capture significant shares in high-value markets has enabled it to bundle lower-priced products, enhancing its overall market position. Medtronic's flagship offerings, such as Admiral IN.PACT™ drug-coated balloons, Endurant™ and Valiant™ stent grafts, along with a range of stents and PTA balloons, have contributed to substantial revenue generation. Furthermore, Medtronic has established dominance in the atherectomy device market, despite its relatively smaller size in Europe.
Cook Medical secured the second-leading position in the PV market, primarily driven by its strong foothold in the stent graft segment. The company also led the inferior vena cava filter (IVCF) market, although it constitutes a smaller portion of its revenue due to the market's size. Cook Medical's Zenith® family of stent grafts stands out as the company's flagship product, contributing significantly to its overall market presence.
Boston Scientific, following its merger with BTG in 2019, initially secured the second-leading position in the European market. However, in 2022, it slipped to the third position due to market share loss to Cook Medical. Nevertheless, Boston Scientific has made notable progress in its venous treatment and transcatheter embolization portfolios after the acquisition, establishing a leading position in both markets. With a comprehensive portfolio for treating venous diseases, Boston Scientific is expected to gradually regain market share in the overall PV market over time.
RESEARCH REGIONAL COVERAGEThroughout our research series, iData Research has extensively covered numerous countries, providing in-depth analysis and insights. Some of the countries we have focused on include:
Germany
France
U.K.
Italy
Spain
Benelux (Belgium, Netherlands, and Luxembourg)
Switzerland
Austria
Portugal
Scandinavia (Denmark, Finland, Norway and Sweden)
SEGMENTS COVEREDPeripheral Vascular Stent Market
PTA Balloon Catheter Market
Drug-Coated Balloon Market
Atherectomy Device Market
Intravascular Lithotripsy Market
CTO Device Market
Surgical Graft Market
Stent Graft Market
Embolic Protection Device Market
Peripheral Thrombus Management Market
Inferior Vena Cava Filter Market
Carotid Shunt Market
Diagnostic and Interventional Catheter Market
Diagnostic and Interventional Guidewire Market
Introducer Sheath Market
Vascular Closure Device Market
Transcatheter Embolization Market
Peripheral IVUS Market
RESEARCH SCOPE SUMMARYRegions: Western Europe, Central & Eastern Europe
Base Year: 2022
Forecast: 2023-2029
Historical Data: 2019-2022
Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.
WHY CHOOSE IDATA?
Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.